Image of the Pont de Cocody in the Cote d'Ivoire
Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Perseus Mining Ltd (ASX:PRU) recorded a December quarter of stronger production and gold sales – as well as slightly higher costs as a result of accelerated waste stripping at the Yaouré gold mine in Cote d’Ivoire.

Production rose 9% during the quarter, reaching 132,419 ounces, while all-in-site costs (AISC) for the same period were US$1,127 per ounce; up from US$1,201.

Production for the first half of the 2025 fiscal year and the 2024 calendar year is at the higher end of guidance, while costs for the same periods were towards the lower end of guidance.

Gold sales were also higher by as much as 20% – comprising 136,623 ounces during the December quarter – with this explained by sales of gold whose shipment had been delayed in the prior comparable period.

Looking ahead, market guidance for the June 2025 half-year is 215,000 to 220,000 ounces at US$1,360 to US$1,435 per ounce, while guidance for the 2025 fiscal year is 469,709 to 504,709 ounces at US$1,250 to US$1,280 per ounce.

Another notable development during the December quarter was Perseus’ Final Investment Decision (FID) to develop the Yaouré gold mine.

Perseus has been trading at $2.73.

Join the discussion: See what HotCopper users are saying about Perseus Mining and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

pru by the numbers
More From The Market Online
The Market Online Video

Market Close: ASX 200 rallies as risk appetite returns, but business confidence weakens

The Australian sharemarket finished firmly higher today with the S&P/ASX 200 adding 106.50 points, or 1.18%, to close at 9,136.20.

EVE Health Group signs Australian compounding agreement for rapidly rising Men’s Health issue

EVE Health Group has signed an agreement with Optimal Pharmacy Plus Stafford aimed at the Australian…

Nanoveu’s EMASS signs DigiKey as Global Distributor for ECS-DoT-22

Nanoveu's wholly-owned subsidiary EMASS has signed DigiKey as its global distributor for ECS-DoT-22 system.
The Market Online Video

Wealth Within: Wall Street Tech Sinks While ASX Tech Soars

Wall Street’s technology stocks have been hammered, with the Nasdaq plunging 5.5 per cent in a single session and Nvidia falling more tha…